Smoking affects the liver directly and indirectly through toxin exposure
A better understanding of the mechanisms and various diverse signaling pathways responsible for nicotine plus HFD-induced NAFLD may also unveil novel pharmacological targets to treat fatty liver disease and adverse metabolic sequelae
Side-stream smoking reduces intestinal inflammation and increases expression of tight junction proteins
Activities might include brisk walking, swimming, cycling, or structured exercise classes
Tests to exclude other causes of liver diseasesuch as viral hepatitis serology, autoimmune markers, ferritin and iron studies, and coeliac screeningmay also be performed
For optimal liver health, avoiding all forms of tobacco is advisable as part of a comprehensive approach to disease prevention